Cargando…

MicroRNA-200b is downregulated in colon cancer budding cells

BACKGROUND: The microRNA-200 (miR-200) family acts as a major suppressor of epithelial-mesenchymal transition (EMT). Impaired miR-200 expression may lead to EMT initiation and eventually cancer dissemination. The presence of tumor budding cells (TBC) is associated with metastasis and poor prognosis,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knudsen, Kirsten Nguyen, Lindebjerg, Jan, Nielsen, Boye Schnack, Hansen, Torben Frøstrup, Sørensen, Flemming Brandt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446202/ https://www.ncbi.nlm.nih.gov/pubmed/28552992 http://dx.doi.org/10.1371/journal.pone.0178564

Ejemplares similares

microRNA-17 Is the Most Up-Regulated Member of the miR-17-92 Cluster during Early Colon Cancer Evolution
por: Knudsen, Kirsten Nguyen, et al.
Publicado: (2015)

miR-21 expression analysis in budding colon cancer cells by confocal slide scanning microscopy
por: Knudsen, Kirsten Nguyen, et al.
Publicado: (2018)

Intra-tumoural vessel area estimated by expression of epidermal growth factor-like domain 7 and microRNA-126 in primary tumours and metastases of patients with colorectal cancer: a descriptive study
por: Hansen, Torben Frøstrup, et al.
Publicado: (2015)

The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer
por: Hansen, Torben Frøstrup, et al.
Publicado: (2012)

Intratumoral Heterogeneity of MicroRNA Expression in Rectal Cancer
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2016)

The prognostic value of microRNA-126 and microvessel density in patients with stage II colon cancer: results from a population cohort
por: Hansen, Torben Frøstrup, et al.
Publicado: (2014)

Prognostic impact of CDX2 in stage II colon cancer: results from two nationwide cohorts
por: Hansen, Torben Frøstrup, et al.
Publicado: (2018)

MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2016)

MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy
por: Hansen, Torben Frøstrup, et al.
Publicado: (2019)

Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2017)

Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlations
por: Zedan, Ahmed Hussein, et al.
Publicado: (2017)

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
por: Eriksen, Ann C., et al.
Publicado: (2018)

Co-Detection of miR-21 and TNF-α mRNA in Budding Cancer Cells in Colorectal Cancer
por: Møller, Trine, et al.
Publicado: (2019)

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
por: Eriksen, Ann Christina, et al.
Publicado: (2018)

The Impact of Patient Characteristics and Tumor Biology on the Accuracy of Preoperative Staging of Colon Cancer in Denmark. A Nationwide Cohort Study
por: Pedersen, Malene Roland V., et al.
Publicado: (2021)

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
por: Hansen, Torben Frøstrup, et al.
Publicado: (2017)

High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients
por: Nielsen, Boye Schnack, et al.
Publicado: (2010)

Astaxanthin suppresses the metastasis of colon cancer by inhibiting the MYC-mediated downregulation of microRNA-29a-3p and microRNA-200a
por: Kim, Hye-Youn, et al.
Publicado: (2019)

CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study
por: Rafaelsen, Søren R., et al.
Publicado: (2022)

Redefining high-risk patients with stage II colon cancer by risk index and microRNA-21: results from a population-based cohort
por: Hansen, T F, et al.
Publicado: (2014)

The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study()
por: Eriksen, Ann C., et al.
Publicado: (2018)

Programmed Death Ligand-1 expression in stage II colon cancer - experiences from a nationwide populationbased cohort
por: Eriksen, Ann C., et al.
Publicado: (2019)

Protective Role of microRNA-200a in Diabetic Retinopathy Through Downregulation of PDLIM1
por: Wan, Wencui, et al.
Publicado: (2021)

MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma
por: Li, Yifan, et al.
Publicado: (2019)

MicroRNA-466 and microRNA-200 increase endothelial permeability in hyperglycemia by targeting Claudin-5
por: Kujawa, Marisa, et al.
Publicado: (2022)

Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
por: Aslan, Derya, et al.
Publicado: (2016)

Re‐exposure to immunotherapy in metastatic colon cancer: A case report
por: Hamre, Tonje Riise, et al.
Publicado: (2021)

The MicroRNA-200 Family Is Upregulated in Endometrial Carcinoma
por: Snowdon, Jaime, et al.
Publicado: (2011)

Emerging Role of MicroRNA-200 Family in Dentistry
por: Hsieh, Pei-Ling, et al.
Publicado: (2021)

Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study
por: Jensen, Lars Henrik, et al.
Publicado: (2023)

Downregulation of microRNA-200c-3p alleviates the aggravation of venous thromboembolism by targeting serpin family C member 1
por: Jian, Xiaorong, et al.
Publicado: (2021)

Regulation of microRNA-200c in cancer stem cells
por: Wu, Meng-Ju, et al.
Publicado: (2015)

The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
por: Paterson, Emily L., et al.
Publicado: (2008)

MicroRNA 200a inhibits liver fibrosis of schistosoma
por: Xu, Ailei, et al.
Publicado: (2021)

MicroRNA-200b and microRNA-200c are up-regulated in PCOS granulosa cell and inhibit KGN cell proliferation via targeting PTEN
por: He, Tingting, et al.
Publicado: (2019)

53BP1 suppresses epithelial–mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer
por: Kong, Xiangnan, et al.
Publicado: (2015)

MicroRNA-141 and MicroRNA-200c Are Overexpressed in Granulosa Cells of Polycystic Ovary Syndrome Patients
por: He, Tingting, et al.
Publicado: (2018)

Colon Cryptogenesis: Asymmetric Budding
por: Tan, Chin Wee, et al.
Publicado: (2013)

Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data
por: Hansen, Torben Frøstrup, et al.
Publicado: (2021)

The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
por: Dizdarevic, Edina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cdv6af2g4g6l7fgsf6kbantjt5